TRCT
MDRX

Tower Research Capital (TRC)’s Veradigm Inc. Common Stock MDRX Stock Holding History

Tower Research Capital (TRC)’s Portfolio MDRX Stock Details MDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-37,374
Closed -$392K – 6294
2023
Q4 		$392K Buy
37,374
+34,534
+1,216% +$423K ﹤0.01% 1570
2023
Q3 		$37.3K Sell
2,840
-2,470
-47% -$32.4K ﹤0.01% 2826
2023
Q2 		$66.9K Buy
5,310
+2,587
+95% +$31.4K ﹤0.01% 2341
2023
Q1 		$36K Buy
2,723
+331
+14% +$5.36K ﹤0.01% 2825
2022
Q4 		$42K Sell
2,392
-14,703
-86% -$246K ﹤0.01% 2487
2022
Q3 		$260K Buy
17,095
+10,113
+145% +$164K ﹤0.01% 1671
2022
Q2 		$104K Sell
6,982
-999
-13% -$18.7K ﹤0.01% 2258
2022
Q1 		$180K Buy
7,981
+4,506
+130% +$91.3K ﹤0.01% 1810
2021
Q4 		$64K Sell
3,475
-24,891
-88% -$395K ﹤0.01% 2574
2021
Q3 		$379K Buy
28,366
+25,225
+803% +$407K 0.01% 1190
2021
Q2 		$58K Sell
3,141
-10,619
-77% -$179K ﹤0.01% 2909
2021
Q1 		$206K Buy
13,760
+2,951
+27% +$47.3K ﹤0.01% 1988
2020
Q4 		$156K Sell
10,809
-224,542
-95% -$2.72M ﹤0.01% 1942
2020
Q3 		$1.92M Buy
235,351
+169,480
+257% +$1.38M 0.02% 427
2020
Q2 		$446K Buy
65,871
+64,725
+5,648% +$420K 0.02% 1130
2020
Q1 		$8K Sell
1,146
-10,334
-90% -$83.9K ﹤0.01% 2143
2019
Q4 		$113K Buy
11,480
+10,177
+781% +$107K 0.01% 866
2019
Q3 		$14K Sell
1,303
-8,406
-87% -$86.3K ﹤0.01% 2742
2019
Q2 		$113K Buy
9,709
+3,070
+46% +$31.2K 0.01% 1106
2019
Q1 		$63K Buy
6,639
+4,517
+213% +$49.9K ﹤0.01% 1657
2018
Q4 		$21K Sell
2,122
-15,739
-88% -$176K ﹤0.01% 1914
2018
Q3 		$255K Buy
17,861
+15,238
+581% +$207K 0.02% 839
2018
Q2 		$31K Sell
2,623
-3,437
-57% -$42.4K ﹤0.01% 2157
2018
Q1 		$75K Buy
6,060
+5,044
+496% +$71.7K 0.01% 1446
2017
Q4 		$15K Sell
1,016
-33,030
-97% -$459K ﹤0.01% 2288
2017
Q3 		$484K Buy
+34,046
New +$440K 0.04% 267
2017
Q2 		– Sell
-1,172
Closed -$15K – 3613
2017
Q1 		$15K Sell
1,172
-12,412
-91% -$147K ﹤0.01% 1505
2016
Q4 		$138K Buy
13,584
+7,672
+130% +$87.5K 0.02% 810
2016
Q3 		$78K Buy
5,912
+4,508
+321% +$60.3K 0.01% 925
2016
Q2 		$18K Sell
1,404
-9,699
-87% -$129K ﹤0.01% 2341
2016
Q1 		$146K Buy
+11,103
New +$146K 0.02% 397
2015
Q4 		– Sell
-3,039
Closed -$38K – 5192
2015
Q3 		$38K Buy
3,039
+1,928
+174% +$26.5K ﹤0.01% 1224
2015
Q2 		$15K Sell
1,111
-2,104
-65% -$28.4K ﹤0.01% 2372
2015
Q1 		$38K Sell
3,215
-329
-9% -$4.02K ﹤0.01% 1706
2014
Q4 		$45K Sell
3,544
-2,312
-39% -$29.5K ﹤0.01% 1085
2014
Q3 		$79K Sell
5,856
-9,834
-63% -$149K 0.01% 1154
2014
Q2 		$252K Buy
15,690
+8,188
+109% +$128K 0.03% 509
2014
Q1 		$135K Sell
7,502
-344
-4% -$5.95K 0.02% 563
2013
Q4 		$121K Sell
7,846
-23,316
-75% -$344K 0.02% 753
2013
Q3 		$463K Buy
31,162
+28,428
+1,040% +$429K 0.05% 351
2013
Q2 		$35K Buy
+2,734
New +$36.6K ﹤0.01% 1224

Other funds holding MDRX

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tower Research Capital (TRC)'s MDRX Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 37,374 shares — an estimated $392K sold.

Tower Research Capital (TRC) first reported a position in MDRX in Q2 2013 and held it in 41 quarters. The position peaked at $1.92M in Q3 2020. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Tower Research Capital (TRC) reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 37,374 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $392K.
  • Tower Research Capital (TRC) first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 41 quarters.
  • Tower Research Capital (TRC)'s Veradigm Inc. Common Stock position peaked at $1.92M in Q3 2020.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.